Passage BIO, Inc. (PASG)
↓ Download CSVKey ratios (FY2025)
-242.7%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Income | -$49.30M | -$70.40M | -$108.39M | -$138.39M | -$185.73M | -$112.90M | -$37.19M | — |
| Net Income | -$45.52M | -$64.77M | -$102.06M | -$136.12M | -$185.39M | -$112.23M | -$45.63M | — |
| EPS (Diluted) | $-14.35 | $-21.04 | $-1.86 | $-2.50 | $-3.48 | $-2.91 | — | — |
| Total Assets | $62.28M | $102.41M | $150.54M | $243.55M | $355.08M | $328.01M | $178.61M | — |
| Total Liabilities | $43.53M | $41.15M | $39.26M | $42.18M | $36.42M | $23.29M | $4.26M | — |
| Shareholders' Equity | $18.75M | $61.26M | $111.28M | $201.37M | $318.66M | $304.71M | -$56.25M | -$12.17M |
| Cash & Equivalents | $46.30M | $37.57M | $21.71M | $34.60M | $128.97M | $135.00M | $158.87M | — |
| Operating Cash Flow | -$31.51M | -$47.96M | -$78.26M | -$118.21M | -$126.88M | -$80.52M | -$39.90M | — |
| Capital Expenditures | — | $34.0K | — | — | — | — | — | — |
| Shares Outstanding | 3.18M | 3.16M | 54.94M | 54.61M | 54.24M | 45.61M | 4.29M | — |